Finance

Beta
Ask
Lists
9989:TYO
Sundrug Co Ltd
Â¥3,809.00
-0.44%
(-17.00) 1D
Jun 12, 11:30:00 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 9989...
Open
Â¥3,829
High
Â¥3,844
Low
Â¥3,794
Mkt. cap
454.53B
Avg. vol.
552.99K
Volume
246.90K
Dividend
3.44%
Quarterly dividend
Â¥33
Ex-dividend date
Mar 30, 2026
P/E ratio
14.19
52-wk high
Â¥4,883
52-wk low
Â¥3,526
EPS
Â¥268
Shares outstanding
116.88M
No. of employees
7K
Open
Â¥3,829
High
Â¥3,844
Low
Â¥3,794
Mkt. cap
454.53B
Avg. vol.
552.99K
Volume
246.90K
Dividend
3.44%
Quarterly dividend
Â¥33
Ex-dividend date
Mar 30, 2026
P/E ratio
14.19
52-wk high
Â¥4,883
52-wk low
Â¥3,526
EPS
Â¥268
Shares outstanding
116.88M
No. of employees
7K
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to 9989 in the past 3 months
Hold
Buy
1
Hold
3
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for 9989 in the last 3 months.
Highest
Current ¥3,809.00
Â¥5,100.00 (+33.89%)
Average
Â¥4,405.39 (+15.66%)
Lowest
Â¥3,920.00 (+2.91%)
News stories
From sources across the web
About Sundrug Co Ltd
CEO-
Employees7.14K
Founded1957
Headquarters-
SectorDrug
Websitesundrug.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
207.70B
210.74B
217.27B
206.80B
Cost of goods sold
154.36B
157.16B
161.24B
153.58B
Cost of revenue
154.36B
157.16B
161.24B
153.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.06B
42.80B
42.55B
24.17B
Operating expense
41.06B
42.80B
42.55B
42.93B
Total operating expenses
195.42B
199.96B
203.79B
196.51B
Operating income
12.28B
10.78B
13.48B
10.30B
Other non operating income
177.00M
188.00M
224.00M
197.00M
EBT including unusual items
12.09B
10.62B
13.25B
9.84B
EBT excluding unusual items
12.14B
10.75B
13.30B
10.02B
Income tax expense
4.14B
3.29B
4.29B
2.68B
Effective tax rate
34.29%
31.01%
32.37%
27.26%
Other operating expenses
-
-
-
-
Net income
7.94B
7.32B
8.96B
7.16B
Net profit margin
3.82%
3.48%
4.12%
3.46%
Earnings per share
-
-
-
-
Interest and investment income
30.00M
86.00M
30.00M
98.00M
Interest expense
-80.00M
-88.00M
-91.00M
-125.00M
Net interest expenses
-50.00M
-2.00M
-61.00M
-27.00M
Depreciation and amortization charges
-
-
-
18.76B
EBITDA
16.60B
15.23B
17.80B
14.98B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer